Drug product
Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5 mg a) 30 count (NDC 68180-413-06) and b) 90 count (NDC 68180-413-09) bottles, Rx only
D-0089-2022
Product summary
- Event
- Event 88856
- Status
- Terminated
- Classification
- Class II
- Quantity
- 63,408 bottles
- Official record key
drug-enforcement:D-0089-2022
Official wording
Reason: CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Code information: a) Lot# H804537, exp. date 30/09/2021 H805148, exp. date 31/10/2021 H900063, exp. date 31/10/2021 H900522, exp. date 31/12/2021 H901582, exp. date 31/01/2022 b) Lot# H000963, exp. date 30/04/2022 H804507, exp. date 30/04/2022 H804536, exp. date 30/09/2021 H805070, exp. date 31/10/2021 H805149, exp. date 31/10/2021 H900064, exp. date 31/12/2021 H900523, exp. date 31/01/2022 H901583, exp. date 30/04/2022 H902530, exp. date 30/04/2022
Distribution pattern: Product was distributed to major distributors who may have further distributed the product nationwide.
Derived failure modes
-
Foreign material or chemical contamination
impurity N-nitrosoirbesartan detected in API
-
Manufacturing or process control
CGMP Deviations